Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807

Cited by (653)

Items 101–200 of 653

1. Tau PET Imaging in Alzheimer’s Disease
   Nobuyuki Okamura, Ryuichi Harada, Shozo Furumoto, Hiroyuki Arai, Kazuhiko Yanai, Yukitsuka Kudo · 2014 · Current Neurology and Neuroscience Reports
2. [¹⁸F]AV‐1451 tau positron emission tomography in progressive supranuclear palsy
   Whitwell, Jennifer L., Lowe, Val J., Tosakulwong, Nirubol, Weigand, Stephen D., Senjem, Matthew L., Schwarz, Christopher G., Spychalla, Anthony J., Petersen, Ronald C., Jack, Clifford R., Josephs, Keith A. · 2017 · Movement Disorders
3. Activated iron-containing microglia in the human hippocampus identified by magnetic resonance imaging in Alzheimer disease
   Zeineh, Michael M., Chen, Yuanxin, Kitzler, Hagen H., Hammond, Robert, Vogel, Hannes, Rutt, Brian K. · 2015 · Neurobiology of Aging
4. A review of neuroimaging findings in repetitive brain trauma
   Koerte, Inga K., Lin, Alexander P., Willems, Anna, Muehlmann, Marc, Hufschmidt, Jakob, Coleman, Michael J., Green, Isobel, Liao, Huijun, Tate, David F., Wilde, Elisabeth A. et al. · 2015 · Brain Pathology
5. Imaging insights into basal ganglia function, Parkinson's disease, and dystonia
   A. Jon Stoessl, Stéphane Lehéricy, Antonio P. Strafella · 2014 · The Lancet
6. Multiple comorbid neuropathologies in the setting of Alzheimer's disease neuropathology and implications for drug development
   Gil Dan Rabinovici, María C. Carrillo, Mark S. Forman, Susan DeSanti, David S. Miller, Nicholas Kozauer, Ronald Carl Petersen, CHRISTOPHER C. RANDOLPH, David S. Knopman, Eric Edward Smith et al. · 2016 · Alzheimer s & Dementia Translational Research & Clinical Interventions
7. Radiosynthesis, Photoisomerization, Biodistribution, and Metabolite Analysis of 11C-PBB3 as a Clinically Useful PET Probe for Imaging of Tau Pathology
   Hiroki Hashimoto, Kazunori Kawamura, Nobuyuki Igarashi, Makoto Takei, Tomoya Fujishiro, Yoshiharu Aihara, Satoshi Shiomi, Masatoshi Muto, Takehito Ito, Kenji Furutsuka et al. · 2014 · Journal of Nuclear Medicine
8. Neuronal mitochondria-targeted delivery of curcumin by biomimetic engineered nanosystems in Alzheimer's disease mice
   Chunhong Gao, Yuli Wang, Jiejie Sun, Han Na Yang, Wei Gong, Yi Li, Ye Feng, Hao Wang, Meiyan Yang, Zhiping Li et al. · 2020 · Acta Biomaterialia
9. Multimodality Review of Amyloid-related Diseases of the Central Nervous System
   Michelle M. Miller‐Thomas, Adam L. Sipe, Tammie L.S. Benzinger, Jonathan McConathy, Sarah Connolly, Katherine E. Schwetye · 2016 · Radiographics
10. Tau, amyloid, and hypometabolism in a patient with posterior cortical atrophy
    Rik Ossenkoppele, Daniel R. Schonhaut, Suzanne L. Baker, James P. O’Neil, Mustafa Janabi, Pia Marie Ghosh, Miguel Santos‐Santos, Zachary Miller, Brianne Magouirk Bettcher, Maria Luisa Gorno‐Tempini et al. · 2014 · Annals of Neurology
11. The tau positron-emission tomography tracer AV-1451 binds with similar affinities to tau fibrils and monoamine oxidases
    Vermeiren, Céline, Motte, Philippe, Viot, Delphine, Mairet‐Coello, Georges, Courade, Jean‐Philippe, Citron, Martin, Mercier, Joël, Hannestad, Jonas, Gillard, Michel · 2018 · Movement Disorders
12. Associations between [ ¹⁸ F]AV1451 tau PET and CSF measures of tau pathology in a clinical sample
    La Joie, Renaud, Bejanin, Alexandre, Fagan, Anne M., Ayakta, Nagehan, Baker, Suzanne L., Bourakova, Viktoriya, Boxer, Adam L., Cha, Jungho, Karydas, Anna, Jerome, Gina et al. · 2018 · Neurology
13. Fluorodeoxyglucose metabolism associated with tau‐amyloid interaction predicts memory decline
    Hanseeuw, Bernard J., Betensky, Rebecca A., Schultz, Aaron P., Papp, Kathryn V., Mormino, Elizabeth C., Sepulcre, Jorge, Bark, John S., Cosio, Danielle M., LaPoint, Molly, Chhatwal, Jasmeer P. et al. · 2017 · Annals of Neurology
14. Tau: From research to clinical development
    Holtzman, David M., Carrillo, Maria C., Hendrix, James A., Bain, Lisa J., Catafau, Ana M., Gault, Laura M., Goedert, Michel, Mandelkow, Eckhard, Mandelkow, Eva‐Maria, Miller, David S. et al. · 2016 · Alzheimer's & Dementia
15. In vivo tau PET imaging in dementia: Pathophysiology, radiotracer quantification, and a systematic review of clinical findings
    Hall, Benjamin, Mak, Elijah, Cervenka, Simon, Aigbirhio, Franklin I., Rowe, James B., O’Brien, John T. · 2017 · Ageing Research Reviews
16. Tauvid™: The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer’s Disease
    Caitlin V. M. L. Jie, V. Treyer, R. Schibli, L. Mu · 2021 · Pharmaceuticals
17. The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects
    Ruben A Smith, Olof T. Strandberg, Niklas Mattsson, Antoine Leuzy, Sebastian Palmqvist, Michael J. Pontecorvo, Michael D. Devous, Rik Ossenkoppele, Oskar Hansson · 2020 · Brain
18. Tau PET Imaging in Neurodegenerative Disorders
    Groot, Colin, Villeneuve, Sylvia, Smith, Ruben, Hansson, Oskar, Ossenkoppele, Rik · 2022 · Journal of Nuclear Medicine
19. Effect of Off-Target Binding on ¹⁸F-Flortaucipir Variability in Healthy Controls Across the Life Span
    Baker, Suzanne L., Harrison, Theresa M., Maass, Anne, La Joie, Renaud, Jagust, William J. · 2019 · Journal of Nuclear Medicine
20. Expression of A152T human tau causes age‐dependent neuronal dysfunction and loss in transgenic mice
    Sumihiro Maeda, Biljana Djukic, Praveen Taneja, Gui-Qiu Yu, Iris Lo, Allyson Davis, Ryan Craft, Weikun Guo, Xin Wang, Daniel Kim et al. · 2016 · EMBO Reports
21. [18F]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer’s disease
    Ryuichi Harada, Nobuyuki Okamura, Shozo Furumoto, Katsutoshi Furukawa, Aiko Ishiki, Naoki Tomita, Kotaro Hiraoka, Shoichi Watanuki, Miho Shidahara, Masayasu Miyake et al. · 2015 · European Journal of Nuclear Medicine and Molecular Imaging
22. Complex Disposition of Methylthioninium Redox Forms Determines Efficacy in Tau Aggregation Inhibitor Therapy for Alzheimer’s Disease
    Thomas C. Baddeley, Jennifer McCaffrey, John M. D. Storey, John K.S. Cheung, Valeria Melis, David Horsley, Charles R. Harrington, Claude M. Wischik · 2014 · Journal of Pharmacology and Experimental Therapeutics
23. Molecular and cellular pathophysiology of preclinical Alzheimer’s disease
    Elliott Jay Mufson, Miloš D. Ikonomović, Scott Counts, Sylvia E. Perez, Michael H. Malek‐Ahmadi, Stephen W. Scheff, Stephen D. Ginsberg · 2016 · Behavioural Brain Research
24. [18F]AV-1451 tau-PET uptake does correlate with quantitatively measured 4R-tau burden in autopsy-confirmed corticobasal degeneration.
    Josephs, Keith A., Whitwell, Jennifer L., Tacik, Pawel, Duffy, Joseph R., Senjem, Matthew L., Tosakulwong, Nirubol, Jack, Clifford R., Lowe, Val, Dickson, Dennis W., Murray, Melissa E. · 2016 · Acta Neuropathologica
25. Chronic Traumatic Encephalopathy: Historical Origins and Current Perspective
    Philip H. Montenigro, Thor D. Stein, Robert C. Cantu, Robert A. Stern · 2015 · Annual Review of Clinical Psychology
26. Depressive Symptoms and Tau Accumulation in the Inferior Temporal Lobe and Entorhinal Cortex in Cognitively Normal Older Adults: A Pilot Study
    Jennifer R. Gatchel, Nancy J. Donovan, Joseph J. Locascio, Aaron P. Schultz, John Alex Becker, Jasmeer P. Chhatwal, Kathryn V. Papp, Rebecca England Amariglio, Dorene M. Rentz, Deborah Blacker et al. · 2017 · Journal of Alzheimer s Disease
27. Rates of β-amyloid accumulation are independent of hippocampal neurodegeneration
    Clifford R. Jack, Heather J. Wiste, David S. Knopman, Prashanthi Vemuri, Michelle M. Mielke, Stephen D. Weigand, Matthew L. Senjem, Jeffrey L. Gunter, Val J. Lowe, Brian E. Gregg et al. · 2014 · Neurology
28. [18F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer’s disease
    Sandra M. Sanabria Bohorquez, Jan Mařı́k, Annie K. Ogasawara, Jeff N. Tinianow, Herman S. Gill, Olivier Barret, Gilles D. Tamagnan, David Alagille, Gai Ayalon, Paul T. Manser et al. · 2019 · European Journal of Nuclear Medicine and Molecular Imaging
29. Neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum
    Bevan-Jones, W Richard, Cope, Thomas E, Jones, P Simon, Kaalund, Sanne S, Passamonti, Luca, Allinson, Kieren, Green, Oliver, Hong, Young T, Fryer, Tim D, Arnold, Robert et al. · 2020 · Brain
30. Tau imaging in neurodegenerative diseases
    Melanie Dani, David James Brooks, Paul Edison · 2015 · European Journal of Nuclear Medicine and Molecular Imaging
31. Small-molecule PET Tracers for Imaging Proteinopathies
    Chester A. Mathis, Brian J. Lopresti, Miloš D. Ikonomović, William Edward Klunk · 2017 · Seminars in Nuclear Medicine
32. Intrinsic connectivity networks in healthy subjects explain clinical variability in Alzheimer’s disease
    Lehmann, Manja, Madison, Cindee M., Ghosh, Pia M., Seeley, William W., Mormino, Elizabeth, Greicius, Michael D., Gorno-Tempini, Maria Luisa, Kramer, Joel H., Miller, Bruce L., Jagust, William J. et al. · 2013 · Proceedings of the National Academy of Sciences
33. <scp>I</scp>ncreased basal ganglia binding of ¹⁸<scp>F‐AV‐1451</scp> in patients with progressive supranuclear palsy
    Smith, Ruben, Schain, Martin, Nilsson, Christer, Strandberg, Olof, Olsson, Tomas, Hägerström, Douglas, Jögi, Jonas, Borroni, Edilio, Schöll, Michael, Honer, Michael et al. · 2017 · Movement Disorders
34. Chronic traumatic encephalopathy: Where are we and where are we going?
    Mez, Jesse, Stern, Robert A., McKee, Ann C. · 2013 · Current Neurology and Neuroscience Reports
35. Amyloid Accumulation and Cognitive Decline in Clinically Normal Older Individuals: Implications for Aging and Early Alzheimer’s Disease
    Elizabeth C. Mormino, Kathryn V. Papp · 2018 · Journal of Alzheimer s Disease
36. Blood-Based Proteomic Biomarkers of Alzheimer’s Disease Pathology
    Alison L. Baird, Sarah Westwood, Simon Lovestone · 2015 · Frontiers in Neurology
37. Advances in CNS PET: the state-of-the-art for new imaging targets for pathophysiology and drug development
    Stuart P. McCluskey, Christophe Plisson, Eugenii A. Rabiner, Oliver David Howes · 2019 · European Journal of Nuclear Medicine and Molecular Imaging
38. Tau‐PET uptake: Regional variation in average SUVR and impact of amyloid deposition
    Prashanthi Vemuri, Val J. Lowe, David S. Knopman, Matthew L. Senjem, Bradley J. Kemp, Christopher G. Schwarz, Scott A. Przybelski, Mary M. Machulda, Ronald Carl Petersen, Clifford R. Jack · 2016 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
39. Aβ-amyloid and Tau Imaging in Dementia
    Villemagne, Victor L., Doré, Vincent, Bourgeat, Pierrick, Burnham, Samantha C., Laws, Simon, Salvado, Olivier, Masters, Colin L., Rowe, Christopher C. · 2017 · Seminars in Nuclear Medicine
40. Relationships between default-mode network connectivity, medial temporal lobe structure, and age-related memory deficits
    Andrew M. Ward, Elizabeth C. Mormino, Willem Huijbers, Aaron P. Schultz, Trey Hedden, Reisa Anne Sperling · 2014 · Neurobiology of Aging
41. In vivo visualization of tau deposits in corticobasal syndrome by 18 F-THK5351 PET
    Akio Kikuchi, Nobuyuki Okamura, Takafumi Hasegawa, Ryuichi Harada, Shoichi Watanuki, Yoshihito Funaki, Kotaro Hiraoka, Toru Baba, Naoto Sugeno, Ryuji Oshima et al. · 2016 · Neurology
42. [F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging
    Marquié, Marta, Siao Tick Chong, Michael, Antón-Fernández, Alejandro, Verwer, Eline E., Sáez-Calveras, Nil, Meltzer, Avery C., Ramanan, Prianca, Amaral, Ana C., Gonzalez, Jose, Normandin, Marc D. et al. · 2017 · Acta Neuropathologica
43. Executive Function Changes before Memory in Preclinical Alzheimer’s Pathology: A Prospective, Cross-Sectional, Case Control Study
    Michael G. Harrington, Jiarong Chiang, Janice M. Pogoda, Megan E. Gomez, Kris Thomas, Sarah Marion, Karen J. Miller, Prabha Siddarth, Xinyao Yi, Feimeng Zhou et al. · 2013 · PLoS ONE
44. Association between tau deposition and antecedent amyloid-β accumulation rates in normal and early symptomatic individuals
    Duygu Tosun, Susan M. Landau, Paul S. S Aisen, Ronald Carl Petersen, Mark A. Mintun, William Jagust, Michael Walter Weiner, Alzheimer’s Disease Neuroimaging Initiative · 2017 · Brain
45. Brain Imaging of Alzheimer Dementia Patients and Elderly Controls with ¹⁸F-MK-6240, a PET Tracer Targeting Neurofibrillary Tangles
    Lohith, Talakad G., Bennacef, Idriss, Vandenberghe, Rik, Vandenbulcke, Mathieu, Salinas, Cristian A., Declercq, Ruben, Reynders, Tom, Telan-Choing, N. Florestina, Riffel, Kerry, Celen, Sofie et al. · 2019 · Journal of Nuclear Medicine
46. Tau Positron Emission Tomography (PET) Imaging: Past, Present, and Future.
    Manuela Ariza, H. Kolb, D. Moechars, F. Rombouts, J. Andrés · 2015 · Journal of Medicinal Chemistry
47. Tau and amyloid β proteins distinctively associate to functional network changes in the aging brain
    Jorge Sepulcre, Mert Rory Sabuncu, Quanzheng Li, Georges El Fakhri, Reisa Anne Sperling, Keith A. Johnson · 2017 · Alzheimer s & Dementia
48. PET Imaging of Neuropathology in Tauopathies: Progressive Supranuclear Palsy
    Kepe, Vladimir, Bordelon, Yvette, Boxer, Adam, Huang, Sung-Cheng, Liu, Jie, Thiede, Frederick C., Mazziotta, John C., Mendez, Mario F., Donoghue, Natacha, Small, Gary W. et al. · 2013 · Journal of Alzheimer's Disease
49. PET Radiopharmaceuticals for Alzheimer’s Disease and Parkinson’s Disease Diagnosis, the Current and Future Landscape
    Bright Chukwunwike Uzuegbunam, Damiano Librizzi, Behrooz H. Yousefi · 2020 · Molecules
50. PET Imaging of Tau Pathology in Alzheimer’s Disease and Tauopathies
    Olga G. James, P. M. Doraiswamy, S. Borges-Neto · 2015 · Frontiers in Neurology
51. Neuroimaging in frontotemporal dementia
    Jonathan Daniel Rohrer, Howard J. Rosen · 2013 · International Review of Psychiatry
52. Characteristics of Tau and Its Ligands in PET Imaging
    Ryuichi Harada, Nobuyuki Okamura, Shozo Furumoto, Tetsuro Tago, Kazuhiko Yanai, Hiroyuki Arai, Yukitsuka Kudo · 2016 · Biomolecules
53. Spreading of amyloid, tau, and microvascular pathology in Alzheimer’s disease: Findings from neuropathological and neuroimaging studies.
    Thal, Dietmar Rudolf, Attems, Johannes, Ewers, Michael · 2014 · Journal of Alzheimer s Disease
54. [18F]AV‐1451 clustering of entorhinal and cortical uptake in Alzheimer's disease
    Jennifer Louise Whitwell, Jonathan Graff‐Radford, Nirubol Tosakulwong, Stephen D. Weigand, Mary M. Machulda, Matthew L. Senjem, Christopher G. Schwarz, Anthony J. Spychalla, David Thomas Jones, Daniel A. Drubach et al. · 2018 · Annals of Neurology
55. In vivo tau imaging: Obstacles and progress
    Victor L. Villemagne, Nobuyuki Okamura · 2014 · Alzheimer s & Dementia
56. Comparing 18 F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease
    Niklas Mattsson, Ruben A Smith, Olof T. Strandberg, Sebastian Palmqvist, Michael Schöll, Philip S. Insel, Douglas Hägerström, Tomas G. Ohlsson, Henrik Zetterberg, Kaj Blennow et al. · 2018 · Neurology
57. Propagation of Tau Pathology: Integrating Insights From Postmortem and In Vivo Studies
    Thomas Vogels, Antoine Leuzy, Claudia Cicognola, Nicholas James Ashton, Tomáš Smolek, Michal Novák, Kaj Blennow, Henrik Zetterberg, Tomáš Hromádka, Norbert Žilka et al. · 2019 · Biological Psychiatry
58. Frontotemporal dementia with the V337M <i>MAPT</i> mutation: Tau-PET and pathology correlations
    Spina, Salvatore, Schonhaut, Daniel R., Boeve, Bradley F., Seeley, William W., Ossenkoppele, Rik, O'Neil, James P., Lazaris, Andreas, Rosen, Howard J., Boxer, Adam L., Perry, David C. et al. · 2017 · Neurology
59. Advances in neuroimaging in frontotemporal dementia
    Elizabeth Gordón, Jonathan Daniel Rohrer, Nick C. Fox · 2016 · Journal of Neurochemistry
60. Current understanding of chronic traumatic encephalopathy
    Baugh, Christine M., Robbins, Clifford A., Stern, Robert A., McKee, Ann C. · 2014 · Current Treatment Options in Neurology
61. Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer’s Disease Patients Measured Using [18F] THK-5351
    Samuel Neal Lockhart, Suzanne L. Baker, Nobuyuki Okamura, Katsutoshi Furukawa, Aiko Ishiki, Shozo Furumoto, Manabu Tashiro, Kazuhiko Yanai, Hiroyuki Arai, Yukitsuka Kudo et al. · 2016 · PLoS ONE
62. Direct Comparison of the Tau PET Tracers18F-Flortaucipir and18F-MK-6240 in Human Subjects
    Alexandra Gogola, Davneet Singh Minhas, Victor L. Villemagne, Ann D. Cohen, James M. Mountz, Tharick Ali Pascoal, Charles M. Laymon, Neale Scott Mason, Miloš D. Ikonomović, Chester A. Mathis et al. · 2021 · Journal of Nuclear Medicine
63. Tau imaging with [¹⁸F]<scp>THK</scp>‐5351 in progressive supranuclear palsy
    Ishiki, A., Harada, R., Okamura, N., Tomita, N., Rowe, C. C., Villemagne, V. L., Yanai, K., Kudo, Y., Arai, H., Furumoto, S. et al. · 2017 · European Journal of Neurology
64. Kinetics of the Tau PET Tracer 18F-AV-1451 (T807) in Subjects with Normal Cognitive Function, Mild Cognitive Impairment, and Alzheimer Disease
    Sergey Shcherbinin, Adam James Schwarz, Abhinay D. Joshi, Michael A. Navitsky, Matthew L. Flitter, William Rodman Shankle, Michael D. Devous, Mark A. Mintun · 2016 · Journal of Nuclear Medicine
65. Biomarkers in Neurodegenerative Diseases
    Jeromin, Andreas, Bowser, Robert · 2017 · Advances in Neurobiology
66. Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants
    Jennifer Louise Whitwell, Nirubol Tosakulwong, Hugo Botha, Farwa Ali, Heather M. Clark, Joseph R. Duffy, Rene L. Utianski, Chase A. Stevens, Stephen D. Weigand, Christopher G. Schwarz et al. · 2019 · NeuroImage Clinical
67. Amyloid, tau and metabolic PET correlates of cognition in early and late-onset Alzheimer’s disease
    Jeremy A. Tanner, Leonardo Iaccarino, Lauren Edwards, Breton Michael Asken, Maria Luisa Gorno‐Tempini, Joel H. Kramer, Julie Q. Pham, David C. Perry, Katherine L. Possin, Maura Malpetti et al. · 2022 · Brain
68. Preclinical Evaluation of 18F-RO6958948, 11C-RO6931643, and 11C-RO6924963 as Novel PET Radiotracers for Imaging Tau Aggregates in Alzheimer Disease
    Michael Honer, Luca B. Gobbi, Henner Knust, Hiroto Kuwabara, Dieter Muri, Matthias Koerner, Heather Valentine, Robert F. Dannals, Dean Foster Wong, Edilio Borroni · 2017 · Journal of Nuclear Medicine
69. [¹⁸F]AV-1451 binding in vivo mirrors the expected distribution of TDP-43 pathology in the semantic variant of primary progressive aphasia
    Bevan-Jones, W R, Cope, Thomas E, Jones, P Simon, Passamonti, Luca, Hong, Young T, Fryer, Tim D, Arnold, Robert, Allinson, Kieren S J, Coles, Jonathan P, Aigbirhio, Franklin I et al. · 2018 · Journal of Neurology, Neurosurgery &amp; Psychiatry
70. Cognitive changes and dementia risk after traumatic brain injury: Implications for aging military personnel
    Andrea S. Vincent, Tresa Roebuck‐Spencer, Alison N. Cernich · 2014 · Alzheimer s & Dementia
71. Identification of three novel radiotracers for imaging aggregated tau in Alzheimer's disease with positron emission tomography
    Gobbi, Luca C., Knust, Henner, Körner, Matthias, Honer, Michael, Czech, Christian, Belli, Sara, Muri, Dieter, Edelmann, Martin R., Hartung, Thomas, Erbsmehl, Isabella et al. · 2017 · Journal of Medicinal Chemistry
72. PART and SNAP
    Clifford R. Jack · 2014 · Acta Neuropathologica
73. The association between tau PET and retrospective cortical thinning in clinically normal elderly
    Molly R. LaPoint, Jasmeer P. Chhatwal, Jorge Sepulcre, Keith A. Johnson, Reisa Anne Sperling, Aaron P. Schultz · 2017 · NeuroImage
74. Head-to-head comparison of tau positron emission tomography tracers [18F]flortaucipir and [18F]RO948
    Smith, Ruben, Schöll, Michael, Leuzy, Antoine, Jögi, Jonas, Ohlsson, Tomas, Strandberg, Olof, Hansson, Oskar · 2020 · European Journal of Nuclear Medicine and Molecular Imaging
75. Molecular imaging in dementia: Past, present, and future
    Robert Jr Laforce, Jean‐Paul Soucy, Leila Sellami, Caroline Dallaire‐Théroux, Francis Brunet, David Bergeron, Bruce L. Miller, Rik Ossenkoppele · 2018 · Alzheimer s & Dementia
76. High Affinity Radiopharmaceuticals Based Upon Lansoprazole for PET Imaging of Aggregated Tau in Alzheimer’s Disease and Progressive Supranuclear Palsy: Synthesis, Preclinical Evaluation, and Lead Selection
    Maria V. Fawaz, Allen Frederick Brooks, Melissa E. Rodnick, Garrett M. Carpenter, Xia Shao, Timothy J. Desmond, Phillip S. Sherman, Carole Quesada, Brian G. Hockley, Michael R. Kilbourn et al. · 2014 · ACS Chemical Neuroscience
77. Quantitative imaging of protein targets in the human brain with PET
    Roger N. Gunn, Mark Slifstein, Graham E. Searle, Julie C. Price · 2015 · Physics in Medicine and Biology
78. Preclinical Evaluation of18F-JNJ64349311, a Novel PET Tracer for Tau Imaging
    Lieven Declercq, Frederik J. R. Rombouts, Michel J. B. Koole, Katleen Fierens, Jonas Mariën, Xavier Langlois, José Ignacio Andrés, Mark E. Schmidt, Gregor J. Macdonald, Diederik Moechars et al. · 2017 · Journal of Nuclear Medicine
79. Plasma p‐tau immunoassays in clinical research for Alzheimer's disease
    Charlotte Elisabeth Teunissen, Rachel Kolster, Gallen Triana‐Baltzer, Shorena Janelidze, Henrik Zetterberg, Hartmuth Christian Kolb · 2024 · Alzheimer s & Dementia
80. Pharmacokinetic Evaluation of the Tau PET Radiotracer 18F-T807 (18F-AV-1451) in Human Subjects
    Dustin Wooten, Nicolas J. Guehl, Eline E. Verwer, Timothy M. Shoup, Daniel L. Yokell, Nevena Zubcevik, Neil Vasdev, ROSS D. ZAFONTE, Keith A. Johnson, Georges El Fakhri et al. · 2016 · Journal of Nuclear Medicine
81. Tau Imaging in Neurodegenerative Diseases Using Positron Emission Tomography
    Yi Ting Wang, Paul Edison · 2019 · Current Neurology and Neuroscience Reports
82. Association between Aβ and tau accumulations and their influence on clinical features in aging and Alzheimer's disease spectrum brains: A [11C]PBB3‐PET study
    Hitoshi Shimada, Soichiro Kitamura, Hitoshi Shinotoh, Hironobu Endo, Fumitoshi Niwa, Shigeki Hirano, Yasuyuki Kimura, Ming‐Rong Zhang, Satoshi Kuwabara, Tetsuya Suhara et al. · 2016 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
83. Alpha Synuclein Fibrils Contain Multiple Binding Sites for Small Molecules
    Chia‐Ju Hsieh, John Joseph Ferrie, Kuiying Xu, Iljung Lee, Thomas J. A. Graham, Zhude Tu, Jennifer Yu, Dhruva D. Dhavale, Paul T. Kotzbauer, E. James Petersson et al. · 2018 · ACS Chemical Neuroscience
84. Amyloid and tau PET demonstrate region-specific associations in normal older people
    Samuel Neal Lockhart, Michael Schöll, Suzanne L. Baker, Nagehan Ayakta, Kaitlin N. Swinnerton, Rachel K. Bell, Taylor J. Mellinger, Vyoma D. Shah, James P. O’Neil, Mustafa Janabi et al. · 2017 · NeuroImage
85. Current Understanding of Neurodegenerative Diseases Associated With the Protein Tau
    Keith A. Josephs · 2017 · Mayo Clinic Proceedings
86. Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer’s disease: a systematic review
    Qingwei Ruan, Grazia D’Onofrio, Daniele Sancarlo, Zhijun Bao, Antonio Greco, Zhuowei Yu · 2016 · BMC Geriatrics
87. Cross‐sectional and longitudinal atrophy is preferentially associated with tau rather than amyloid β positron emission tomography pathology
    Brian Andrew Gordon, Austin A. McCullough, Shruti Mishra, Tyler Blazey, Yi Su, John Christensen, Aylin Dincer, Kelley Jackson, Russ C. Hornbeck, John C. Morris et al. · 2018 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
88. Test-retest reproducibility for the tau PET imaging agent flortaucipir F 18.
    Devous, Michael D., Joshi, Abhinay D., Navitsky, Michael, Southekal, Sudeepti, Pontecorvo, Michael J., Shen, Haiqing, Lu, Ming, Shankle, William R., Seibyl, John P., Marek, Ken et al. · 2018 · Journal of Nuclear Medicine
89. A concise radiosynthesis of the tau radiopharmaceutical, [18F]T807
    Timothy M. Shoup, Daniel L. Yokell, Peter A. Rice, Raul N. Jackson, Eli Livni, Keith A. Johnson, Thomas J. Brady, Neil Vasdev · 2013 · Journal of Labelled Compounds and Radiopharmaceuticals
90. Neuroimaging of Inflammation in Memory and Related Other Disorders (NIMROD) study protocol: a deep phenotyping cohort study of the role of brain inflammation in dementia, depression and other neurological illnesses
    William Richard Bevan-Jones, Ajenthan Surendranathan, Luca Passamonti, Patricia Vázquez Rodríguez, Robert J. Arnold, Elijah Mak, Li Su, Jonathan Coles, Tim D. Fryer, Young T. Hong et al. · 2017 · BMJ Open
91. Tau-mediated Neurodegeneration and Potential Implications in Diagnosis and Treatment of Alzheimer's Disease
    Xilin Wu, Juan Piña-Crespo, Yun‐wu Zhang, Xiaochun Chen, Huaxi Xu · 2017 · Chinese Medical Journal
92. Regional Distribution, Asymmetry, and Clinical Correlates of Tau Uptake on [ ¹⁸ F]AV-1451 PET in Atypical Alzheimer’s Disease
    Tetzloff, Katerina A., Graff-Radford, Jonathan, Martin, Peter R., Tosakulwong, Nirubol, Machulda, Mary M., Duffy, Joseph R., Clark, Heather M., Senjem, Matthew L., Schwarz, Christopher G., Spychalla, Anthony J. et al. · 2018 · Journal of Alzheimer’s Disease
93. Longitudinal Assessment of Tau Pathology in Patients with Alzheimer’s Disease Using [18F]THK-5117 Positron Emission Tomography
    Aiko Ishiki, Nobuyuki Okamura, Katsutoshi Furukawa, Shozo Furumoto, Ryuichi Harada, Naoki Tomita, Kotaro Hiraoka, Shoichi Watanuki, Yoichi Ishikawa, Tetsuro Tago et al. · 2015 · PLoS ONE
94. Overview of tau PET molecular imaging
    Gabriel Cassinelli Petersen, Michelle Roytman, Gloria Chia-Yi Chiang, Yi Li, Marc L. Gordon, Ana M. Franceschi · 2022 · Current Opinion in Neurology
95. Asymmetry of post-mortem neuropathology in behavioural-variant frontotemporal dementia
    David John Irwin, Corey T. McMillan, Sharon Xiangwen Xie, Katya Rascovsky, Vivianna M. Van Deerlin, H. Branch Coslett, Roy H. Hamilton, Geoffrey K. Aguirre, Edward B. Lee, Virginia M.‐Y. Lee et al. · 2017 · Brain
96. Comparative In Vitro and In Vivo Quantifications of Pathologic Tau Deposits and Their Association with Neurodegeneration in Tauopathy Mouse Models
    Ni, Ruiqing, Ji, Bin, Ono, Maiko, Sahara, Naruhiko, Zhang, Ming-Rong, Aoki, Ichio, Nordberg, Agneta, Suhara, Tetsuya, Higuchi, Makoto · 2018 · Journal of Nuclear Medicine
97. Kinetic Modeling of the Tau PET Tracer 18F-AV-1451 in Human Healthy Volunteers and Alzheimer Disease Subjects
    Olivier Barret, David Alagille, Sandra Sanabria, Robert A. Comley, Robby M. Weimer, Edilio Borroni, Mark A. Mintun, Nicholas M. Seneca, Caroline Papin, Thomas J. Morley et al. · 2016 · Journal of Nuclear Medicine
98. Hierarchical Organization of Tau and Amyloid Deposits in the Cerebral Cortex
    Sepulcre, Jorge, Grothe, Michel J., Sabuncu, Mert, Chhatwal, Jasmeer, Schultz, Aaron P., Hanseeuw, Bernard, El Fakhri, Georges, Sperling, Reisa, Johnson, Keith A. · 2017 · JAMA Neurology
99. Multimodality Imaging of Alzheimer Disease and Other Neurodegenerative Dementias
    Ilya M. Nasrallah, David A. Wolk · 2014 · Journal of Nuclear Medicine
100. Fluorescence and autoradiographic evaluation of tau PET ligand PBB3 to α‐synuclein pathology
     Shunsuke Koga, Maiko Ono, Naruhiko Sahara, Makoto Higuchi, Dennis W. Dickson · 2017 · Movement Disorders